CH
NXL icon

CVI Holdings’s Nexalin Technology NXL Stock Holding History

CVI Holdings’s Portfolio NXL Stock Details NXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$93.7K Buy
+55,462
New +$81.6K 0.08% 42

Other funds holding NXL

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AWS
Atria Wealth Solutions New York $4.42B AUM 16.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
SHIM
Stone House Investment Management Tunkhannock, Pennsylvania $752M AUM 20.1% 1-Year Est. Return

CVI Holdings's NXL Position: Q2 2024 in Review

CVI Holdings opened a new position in Nexalin Technology (NXL) in Q2 2024: 55,462 shares worth $93.7K. The stake represents 0.08% of the portfolio and ranks #42 among its holdings.

13 funds tracked by Wall St. Rank hold NXL as of Q2 2024.

  • CVI Holdings held 55,462 shares of Nexalin Technology worth $93.7K as of Q2 2024.
  • Nexalin Technology was a new CVI Holdings position in Q2 2024.
  • Nexalin Technology made up 0.08% of CVI Holdings's portfolio in Q2 2024, its #42 holding.
  • 13 funds tracked by Wall St. Rank held Nexalin Technology as of Q2 2024.

Based on CVI Holdings's 13F filing for Q2 2024, filed 15 Aug 2024.